Baljinder Bhullar insider trades
Open-market stock purchases and sales by Baljinder Bhullar, Director at Lexaria Bioscience Corp, from SEC Form 4 filings since Dec 30, 2009.
Track record: 44% of 9 scored buys are up 5% or more since purchase, averaging +6%.
Recent trades
No open-market trades in the last 12 months.